Vistagen Therapeutics (VTGN) Cash & Equivalents (2011 - 2026)
Vistagen Therapeutics (VTGN) posted Cash & Equivalents of $16.99 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 65.3% from $48.99 million a year earlier and down 44.8% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Cash & Equivalents (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Cash & Equivalents came in at $30.79 million, down 54.1% from FY2025.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -21.5% (FY2021 to FY2026).
- In prior fiscal years, Vistagen Therapeutics' Cash & Equivalents was $67.13 million in FY2025 (-43.7%), $119.17 million in FY2024 (+616.2%), $16.64 million in FY2023 (-75.6%) and $68.14 million in FY2022 (-33.9%).
- The fiscal Q1 2027 figure stands as the lowest quarterly Cash & Equivalents since fiscal Q1 2024.
- On a year-over-year basis, Cash & Equivalents has declined in each of the last seven quarters, with an average decline of 24.3% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was fiscal Q1 2025, with growth of 969.6%; the weakest was fiscal Q1 2024, with a decline of 81.5%.
- According to Business Quant data, Cash & Equivalents for the three prior fiscal quarters was $30.79 million (Q4 2026), $47.37 million (Q3 2026) and $62.79 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Vistagen Therapeutics | 12.43 Mn | 12.43 Mn | - | 16.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.99 Mn |
| Mar 31, 2026 | 30.79 Mn |
| Dec 31, 2025 | 47.37 Mn |
| Sep 30, 2025 | 62.79 Mn |
| Jun 30, 2025 | 48.99 Mn |
| Mar 31, 2025 | 67.13 Mn |
| Dec 31, 2024 | 74.72 Mn |
| Sep 30, 2024 | 84.25 Mn |
| Jun 30, 2024 | 102.92 Mn |
| Mar 31, 2024 | 119.17 Mn |
| Dec 31, 2023 | 126.60 Mn |
| Sep 30, 2023 | 37.61 Mn |
| Jun 30, 2023 | 9.62 Mn |
| Mar 31, 2023 | 16.64 Mn |
| Dec 31, 2022 | 25.04 Mn |
| Sep 30, 2022 | 35.30 Mn |
| Jun 30, 2022 | 52.00 Mn |
| Mar 31, 2022 | 68.14 Mn |
| Dec 31, 2021 | 83.70 Mn |
| Sep 30, 2021 | 93.63 Mn |
API Access
Vistagen Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();